LYCERA

lycera-logo

Lycera is a preclinical-stage biopharma company focused on small molecule immunomodulators for the treatment of rheumatoid arthritis, lupus erythematosus, and inflammatory bowel disease Lycera's first-in-class drugs are designed to treat immune disorders. The company's technology platforms include proprietary small molecules that modulate a target, which is central to cellular bioenergetics along with molecules that target the Th17 pathway. Drugs that emerge from the Lycera pipeline will represent first-in-class agents that have the potential for first-in-class oral efficacy without the adverse effects of current standard-of-care antiproliferative and immunosuppressive agents.

#SimilarOrganizations #People #Financial #Website #More

LYCERA

Social Links:

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2006-01-01

Address:
Ann Arbor, Michigan, United States

Country:
United States

Website Url:
http://www.lycera.com

Total Employee:
51+

Status:
Active

Contact:
7342333147

Email Addresses:
[email protected]

Total Funding:
85.89 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Content Delivery Network Google Universal Analytics


Similar Organizations

advaxis-logo

Advaxis

Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

navitor-pharmaceuticals-logo

Navitor Pharmaceuticals

Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.


Current Advisors List

laura-carter_image

Laura Carter Senior Vice President, Biology @ Lycera
Board_member

michael-steinmetz_image

Michael Steinmetz Board of Directors @ Lycera
Board_member

robert-kamen_image

Robert Kamen Board of Directors @ Lycera
Board_member
2009-01-01

nina-kjellson_image

Nina Kjellson Board Member @ Lycera
Board_member
2008-02-01

peter-toogood_image

Peter Toogood Senior Vice President, Chemistry and Chemical Biology @ Lycera
Board_member

kristina-burow_image

Kristina Burow Board of Directors @ Lycera
Board_member

joann-scatina_image

JoAnn Scatina Senior Vice President, Preclinical Development @ Lycera
Board_member

steven-gillis_image

Steven Gillis Chairman of the Board of Directors @ Lycera
Board_member

Current Employees Featured

not_available_image

Anthony Opipari
Anthony Opipari Founder @ Lycera
Founder

Founder


not_available_image

Anthony Opipari

gary-glick_image

Gary Glick

Investors List

clarus-ventures_image

Clarus Ventures

Clarus Ventures investment in Series A - Lycera

edf-ventures_image

EDF Ventures

EDF Ventures investment in Series A - Lycera

clarus-ventures_image

Clarus Ventures

Clarus Ventures investment in Series A - Lycera

interwest-partners_image

InterWest Partners

InterWest Partners investment in Series A - Lycera

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series A - Lycera

wolverine-venture-fund_image

Wolverine Venture Fund

Wolverine Venture Fund investment in Venture Round - Lycera

edf-ventures_image

EDF Ventures

EDF Ventures investment in Seed Round - Lycera

Official Site Inspections

http://www.lycera.com

  • Host name: 208.91.197.44
  • IP address: 208.91.197.44
  • Location: British Virgin Islands
  • Latitude: 18.5
  • Longitude: -64.5
  • Timezone: America/Tortola

Loading ...

More informations about "Lycera" on Search Engine